Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France

• S. Dalle,
• P. Saiag,
• C. Lebbé,
• J.-J. Grob,
• B. Dréno,
• S. Dalac,
• B. Asselain,
• F. Skowron,
• S. Darras,
• N. Jovenin,
• G. Quereux,
• A. Khammari,
• C. Rieuf,
• F. Brellier,
• S. Houssou,
• L. Mortier

Affiliations

S. Dalle

Lyon Sud Hospital, Department of Dermatology, Lyon, France

P. Saiag

Ambroise Paré Hospital, Department of Dermatology, Boulogne Billancourt, France

C. Lebbé

Saint Louis Hospital, Paris Cite University, APHP Dermato oncology and CIC, Cancer Institute APHP Nord Paris Cité INSERM U976, Paris, France

J.-J. Grob

APHM Timone Hospital, Department of Dermatology, Marseille, France

B. Dréno

Nantes University, Nantes University Hospital, CIC 1413, Inserm UMR 1302/EMR6001 INCIT, Nantes, France

S. Dalac

Dijon Bourgogne University Hospital, Department of Dermatology, Dijon, France

B. Asselain

GINECO group Paris France, Department of Biostatistics, Paris, France

F. Skowron

Drôme Nord Hospital, Department of Dermatology, Romans sur Isère, France

S. Darras

Boulogne sur Mer Hospital, Department of Dermatology, Boulogne sur Mer, France

N. Jovenin

Courlancy Polyclinic, Department of Oncology, Reims, France

G. Quereux

Nantes University, Nantes University Hospital, Department of Dermatology, CIC 1413, Inserm UMR 1302/EMR6001 INCIT, Nantes, France

A. Khammari

Nantes University, Nantes University Hospital, Department of Dermatology, CIC 1413, Inserm UMR 1302/EMR6001 INCIT, Nantes, France

C. Rieuf

Bristol Myers Squibb, Rueil Malmaison, France

F. Brellier

Bristol Myers Squibb, Rueil Malmaison, France

S. Houssou

Bristol Myers Squibb, Rueil Malmaison, France

L. Mortier

Lille University Hospital, Department of Dermatology, Lille, France